Advanced Enzyme Technologies (NSE:ADVENZYMES) EV-to-FCF: (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ADVENZYMES Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
89 GF Score
Price ₹324.35
GF Value ₹420.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Advanced Enzyme Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Advanced Enzyme Technologies's Enterprise Value is ₹30,079 Mil. Advanced Enzyme Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, Advanced Enzyme Technologies's EV-to-FCF for today is .

The historical rank and industry rank for Advanced Enzyme Technologies's EV-to-FCF or its related term are showing as below:

NSE:ADVENZYMES' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 28.81
Current: 28.81

During the past 13 years, the highest EV-to-FCF of Advanced Enzyme Technologies was 28.81. The lowest was 0.00. And the median was 0.00.

NSE:ADVENZYMES's EV-to-FCF is ranked worse than
57.94% of 932 companies
in the Chemicals industry
Industry Median: 21.465 vs NSE:ADVENZYMES: 28.81

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-09), Advanced Enzyme Technologies's stock price is ₹324.35. Advanced Enzyme Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹15.070. Therefore, Advanced Enzyme Technologies's PE Ratio (TTM) for today is 21.52.


Advanced Enzyme Technologies  (NSE:ADVENZYMES) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Advanced Enzyme Technologies's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=324.35/15.070
=21.52

Advanced Enzyme Technologies's share price for today is ₹324.35.
Advanced Enzyme Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹15.070.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Advanced Enzyme Technologies EV-to-FCF Related Terms


Advanced Enzyme Technologies EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Advanced Enzyme Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Enzyme Technologies EV-to-FCF Chart

Advanced Enzyme Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.46 21.46 36.60 24.31 21.39

Advanced Enzyme Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.31 0.00 0.00 0.00 21.39

NSE:ADVENZYMES vs LIN, SHW, ECL: EV-to-FCF Comparison

For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Enzyme Technologies EV-to-FCF vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Advanced Enzyme Technologies's EV-to-FCF falls into.


NSE:ADVENZYMES
89GF Score
Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Enzyme Technologies EV-to-FCF Calculation

Advanced Enzyme Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=30079.244/0
=

Advanced Enzyme Technologies's current Enterprise Value is ₹30,079 Mil.
Advanced Enzyme Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued. The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89. GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.

Key valuation signals for NSE:ADVENZYMES:

  • EV-to-FCF:
  • GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Enzyme Technologies Business Description

Other Exchanges 540025:India
Address Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score

Get the complete analysis for NSE:ADVENZYMES

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹324.35
Price
₹420.89
GF Value